Antibiotic injection Rocephin linked to newborn deaths
The FDA reported today that a new warning will be added to Rocephin for Injection, an antibiotic manufactured by Roche Holding AG. When combined with calcium or calcium-containing products, the antibiotic could cause a fatal reaction in the lungs and kidneys of newborn babies, especially those born premature.
>>FDA LINK: Antibiotic Rocephin Injection Warning
Rocephin (generic ceftriaxone sodium) has been linked to an unspecified number of deaths for recently born babies. The new warning will indicate that the antibiotic injection should not be given to hyperbilirubinemic newborns, especially premature babies. Also, the drug should not be mixed or administered within 48 hours of any solutions or products which contain calcium, even if they are given through different infusion lines.
Deaths have been reported as a result of reactions with calcium and Recephin which occurs in the lungs or kidneys. It has been seen in both full term babies and premature newborns.
If your child or loved one suffered a fatal reaction as a newborn after receiving the antibiotic Rocephin injection, request a free legal consultation.
